135 related articles for article (PubMed ID: 34341212)
1. Chronic myeloid leukaemia after chemoradiotherapy for solid malignancies.
Baysal M; Ulutas G; Gokyer A; Umit E; Atli EI; Kirkizlar O; Gürkan H; Demir AM
Natl Med J India; 2020; 33(6):347-348. PubMed ID: 34341212
[TBL] [Abstract][Full Text] [Related]
2. Expression of the leucocyte common antigen (LCA, CD45) isoforms RA and RO in acute haematological malignancies: possible relevance in the definition of new overlap points between normal and leukaemic haemopoiesis.
Schiavone EM; Lo Pardo C; Di Noto R; Manzo C; Ferrara F; Vacca C; Del Vecchio L
Br J Haematol; 1995 Dec; 91(4):899-906. PubMed ID: 8547136
[TBL] [Abstract][Full Text] [Related]
3. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
[TBL] [Abstract][Full Text] [Related]
4. Cancer in relatives of children with myelodysplastic syndrome, acute and chronic myeloid leukaemia.
Hasle H; Olsen JH
Br J Haematol; 1997 Apr; 97(1):127-31. PubMed ID: 9136952
[TBL] [Abstract][Full Text] [Related]
5. Homoharringtonine and omacetaxine for myeloid hematological malignancies.
Lü S; Wang J
J Hematol Oncol; 2014 Jan; 7():2. PubMed ID: 24387717
[TBL] [Abstract][Full Text] [Related]
6. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
Xu F; Taki T; Yang HW; Hanada R; Hongo T; Ohnishi H; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379
[TBL] [Abstract][Full Text] [Related]
7. Real-time quantitation of bcr-abl transcripts in haematological malignancies.
Saffroy R; Lemoine A; Brézillon P; Frénoy N; Delmas B; Goldschmidt E; Souleau B; Nedellec G; Debuire B
Eur J Haematol; 2000 Oct; 65(4):258-66. PubMed ID: 11073166
[TBL] [Abstract][Full Text] [Related]
8. Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta-analysis.
Teras LR; Patel AV; Carter BD; Rees-Punia E; McCullough ML; Gapstur SM
Br J Haematol; 2019 Jul; 186(2):243-254. PubMed ID: 30977126
[TBL] [Abstract][Full Text] [Related]
9. Haematological classification of the chronic myeloid leukaemias.
Shepherd PC; Ganesan TS; Galton DA
Baillieres Clin Haematol; 1987 Dec; 1(4):887-906. PubMed ID: 3332855
[TBL] [Abstract][Full Text] [Related]
10. Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study.
Martinelli G; Oehler VG; Papayannidis C; Courtney R; Shaik MN; Zhang X; O'Connell A; McLachlan KR; Zheng X; Radich J; Baccarani M; Kantarjian HM; Levin WJ; Cortes JE; Jamieson C
Lancet Haematol; 2015 Aug; 2(8):e339-46. PubMed ID: 26688487
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Zhang W; Yang L; Yan Y; Lin J; Qian J
J Cell Mol Med; 2017 Aug; 21(8):1468-1481. PubMed ID: 28452111
[TBL] [Abstract][Full Text] [Related]
12. Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
Jabbour E; Garcia-Manero G; Cortes J; Ravandi F; Plunkett W; Gandhi V; Faderl S; O'Brien S; Borthakur G; Kadia T; Burger J; Konopleva M; Brandt M; Huang X; Kantarjian H
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):244-51. PubMed ID: 22534616
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia.
Kovitz C; Kantarjian H; Garcia-Manero G; Abruzzo LV; Cortes J
Blood; 2006 Oct; 108(8):2811-3. PubMed ID: 16809614
[TBL] [Abstract][Full Text] [Related]
14. [Differential diagnosis of chronic myeloid leukemia and the related disorders].
Ashida T; Kanamaru A
Nihon Rinsho; 2001 Dec; 59(12):2358-62. PubMed ID: 11766339
[TBL] [Abstract][Full Text] [Related]
15. The role of cytology, cytochemistry, immunophenotyping and cytogenetic analysis in the diagnosis of haematological neoplasms. General Haematology Task Force of the BCSH.
Clin Lab Haematol; 1996 Dec; 18(4):231-6. PubMed ID: 9054693
[TBL] [Abstract][Full Text] [Related]
16. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia.
Galton DA
Leuk Lymphoma; 1992 Aug; 7(5-6):343-50. PubMed ID: 1493435
[TBL] [Abstract][Full Text] [Related]
17. P230 BCR/ABL protein may be associated with an acute leukaemia phenotype.
Haskovec C; Ponzetto C; Polák J; Maritano D; Zemanová Z; Serra A; Michalová K; Klamová H; Cermák J; Saglio G
Br J Haematol; 1998 Dec; 103(4):1104-8. PubMed ID: 9886327
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia.
McCormack PL; Keam SJ
Drugs; 2011 Sep; 71(13):1771-95. PubMed ID: 21902298
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
Winfield DA; Polacarz SV
J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
[No Abstract] [Full Text] [Related]
20. What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?
Gale RP; Apperley J
Curr Hematol Malig Rep; 2019 Dec; 14(6):477-479. PubMed ID: 31858440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
